Literature DB >> 9741366

Chlamydia pneumoniae and asthma.

P J Cook1, P Davies, W Tunnicliffe, J G Ayres, D Honeybourne, R Wise.   

Abstract

BACKGROUND: This study was designed to test the association of Chlamydia pneumoniae infection with asthma in a multi-racial population, after adjustments for several potential confounding variables.
METHODS: Antibodies to C pneumoniae were measured by microimmunofluorescence in 123 patients with acute asthma, 1518 control subjects admitted to the same hospital with various non-cardiovascular, non-pulmonary disorders, and 46 patients with severe chronic asthma, including some with "brittle" asthma. Acute infection or reinfection was defined by titres of IgG of > or = 512 or IgM > or = 8 or a fourfold rise in IgG, and previous infection by IgG 64-256 or IgA > or = 8. Logistic regression was used to control for likely confounders, including ethnic origin, age, sex, smoking habit, steroid medication, diabetes mellitus and social deprivation, on antibody levels.
RESULTS: Antibody titres consistent with acute C pneumoniae infection were found in 5.7% of patients with acute asthma and 5.7% of control patients, while 14.6% of patients with acute asthma and 12.7% of control patients had titres suggesting previous infection. These two groups did not differ significantly. However, titres suggesting previous infection were found in 34.8% of patients with severe chronic asthma: the difference between this group and the control group was statistically significant with an adjusted odds ratio of 3.99 (95% confidence interval 1.60 to 9.97).
CONCLUSIONS: These data raise important questions about the previously demonstrated association of C pneumoniae infection with asthma, and suggest that future studies of this association should give particular attention to the presence or absence of a history of severe chronic asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741366      PMCID: PMC1745183          DOI: 10.1136/thx.53.4.254

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  39 in total

1.  Asthma and IgE levels in rural and urban communities of The Gambia.

Authors:  R C Godfrey
Journal:  Clin Allergy       Date:  1975-06

2.  Resection rates in lung cancer patients.

Authors:  K Moghissi; C K Connolly
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

3.  Human serology in Chlamydia trachomatis infection with microimmunofluorescence.

Authors:  S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

4.  Prevalence of asthma: a comparative study of urban and rural Xhosa children.

Authors:  C H Van Niekerk; E G Weinberg; S C Shore; H V Heese; J Van Schalkwyk
Journal:  Clin Allergy       Date:  1979-07

Review 5.  The eosinophil and the pathophysiology of asthma.

Authors:  E Frigas; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1986-04       Impact factor: 10.793

6.  Comparison between cell culture and serology for detecting Chlamydia trachomatis in women seeking abortion.

Authors:  P A Csángó; B Sarov; H Schiøtz; I Sarov
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

7.  Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia.

Authors:  T Forsey; S Darougar; J D Treharne
Journal:  J Infect       Date:  1986-03       Impact factor: 6.072

8.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

10.  Cigarette smoking and upper respiratory infection among recruits in basic combat training.

Authors:  G H Blake; T D Abell; W G Stanley
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

View more
  22 in total

1.  Infections prevent the development of asthma--true, false or both?

Authors:  P J Openshaw; G Walzl
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

2.  Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.

Authors:  Dario Caronzolo; Valeria Lucini; Marilou Pannacci; Silvia Grosso; Federica Colleoni; Franco Fraschini; Francesco Scaglione
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Serological Evidence of Chronic Chlamydia pneumoniae Infection in Coronary Artery Disease.

Authors:  A Agarwal; Y Chander; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae.

Authors:  J Rödel; M Woytas; A Groh; K H Schmidt; M Hartmann; M Lehmann; E Straube
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice.

Authors:  Hong Wei Chu; Joyce M Honour; Catherine A Rawlinson; Ronald J Harbeck; Richard J Martin
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

6.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

7.  Atypical bacteria and macrolides in asthma.

Authors:  Paraskevi Xepapadaki; Ioanna Koutsoumpari; Vasiliki Papaevagelou; Christina Karagianni; Nikolaos G Papadopoulos
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

8.  Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.

Authors:  Chan-Sun Park; Tae-Bum Kim; Keun Ae Moon; Yun-Jeong Bae; Hee Ran Lee; Min Kyoung Jang; Hee-Bom Moon; You Sook Cho
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

9.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016

10.  Chlamydia Species and Mycoplasma pneumoniae.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.